(Q38115703)

29 August 2017

title

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes (English)

1 reference

29 August 2017

0 references

0 references

0 references

1 reference

Rituraj Niranjan

1

1 reference

29 August 2017

publication date

20 June 2013

1 reference

29 August 2017

published in

Molecular Neurobiology

1 reference

29 August 2017

volume

49

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

28-38

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-013-8483-x

29 August 2017

exact match

0 references

cites work

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The role of neuroimmunomodulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Evaluation of guggulipid and nimesulide on production of inflammatory mediators and GFAP expression in LPS stimulated rat astrocytoma, cell line (C6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Glial dysfunction in parkin null mice: effects of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Microglia: gatekeepers of central nervous system immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Guggulipid and nimesulide differentially regulated inflammatory genes mRNA expressions via inhibition of NF-kB and CHOP activation in LPS-stimulated rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Microglial activation and its implications in the brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

What is the harm-benefit ratio of Cox-2 inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

TNF-alpha expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

MPTP: insights into parkinsonian neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Multiple antioxidants in the prevention and treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Selective types of autophagy in yeast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Interleukin-6 serum levels in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The NADPH oxidase is involved in lipopolysaccharide-mediated motor neuron injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Anti-inflammatory actions of a taurine analogue, ethane β-sultam, in phagocytic cells, in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

IL-1 beta-dependent regulation of C/EBP delta transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Temporal gene expression patterns in G93A/SOD1 mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation, COX-2, and ALS--a dual role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Prostaglandins and cyclooxygenases in glial cells during brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Interactions between cortical rhythms and spiking activity of single basal ganglia neurons in the normal and parkinsonian state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Microglia: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Divergent role of calcium on Abeta- and MPTP-induced cell death in SK-N-SH neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Potentiation of methamphetamine neurotoxicity by intrastriatal lipopolysaccharide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Astrocytes in Parkinson's disease and DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Astrocyte-derived GDNF is a potent inhibitor of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Melatonin attenuated mediators of neuroinflammation and alpha-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Genomic analysis of reactive astrogliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Neuroinflammation alters voltage-dependent conductance in striatal astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

Cobalt(II) β-ketoaminato complexes as novel inhibitors of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-013-8483-X

[Oxidative stress in human diseases]

21 January 2018

1 reference

12 December 2020

[Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept]

1 reference

12 December 2020

The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6.

1 reference

12 December 2020

The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice.

1 reference

12 December 2020

[Antioxidants in complex treatment of Parkinson's disease].

1 reference

12 December 2020

Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies

1 reference

12 December 2020

Epidemiology of Parkinson's disease

1 reference

12 December 2020

Mitochondria, oxidative damage, and inflammation in Parkinson's disease

1 reference

12 December 2020

Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain

1 reference

12 December 2020

Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage

1 reference

12 December 2020

Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?

1 reference

12 December 2020

Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

1 reference

12 December 2020

Mitochondrial dysfunction in Parkinson's disease

1 reference

12 December 2020

Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia

1 reference

12 December 2020

Changes in cytokines and neurotrophins in Parkinson's disease

1 reference

12 December 2020

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention

1 reference

12 December 2020

Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1

1 reference

12 December 2020

MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies

1 reference

12 December 2020

1 reference

12 December 2020

TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease

1 reference

12 December 2020

Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration.

1 reference

12 December 2020

Astrocytes and therapeutics for Parkinson's disease

1 reference

12 December 2020

Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study

1 reference

12 December 2020

Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines.

1 reference

12 December 2020

Neuromodulation in a minipig MPTP model of Parkinson disease

1 reference

12 December 2020

The role of glial reaction and inflammation in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12035-013-8483-X

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1028666444

0 references

1 reference